77
Views
6
CrossRef citations to date
0
Altmetric
Supplementary Article

InforMatrix as an alternative tool in rational and transparent drug-decision making

, PharmD, , Bsc, Phd, MPA, MCIPS, MPSNI, , BPharm, Msc, PhD, MPSNI, , PhD, MCPP, FPSNI, , Bsc, PhD, FCPP, FPSNI & , PharmD, PhD
Pages S31-S36 | Published online: 11 Oct 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Robert Janknegt, Adrianne Faber, Rob Rodrigues Pereira & Luuk J Kalverdijk. (2009) InforMatrix for attention deficit hyperactivity disorder. Expert Opinion on Pharmacotherapy 10:5, pages 755-772.
Read now
Mike Scott, Mark Timoney, Jill Mairs, Grainne Crealey, Ibrahim Al Abaddi, Rob Brenninkmeijer, Robert Janknegt & James McElnay. (2007) Safe Therapeutic Economic Pharmaceutical Selection (STEPS): development, introduction and use in Northern Ireland. Expert Opinion on Pharmacotherapy 8:sup1, pages S57-S63.
Read now
Robert Janknegt, Mike Scott, Jill Mairs, Mark Timoney, James McElnay & Rob Brenninkmeijer. (2007) System of Objectified Judgement Analysis (SOJA) as a tool in rational and transparent drug-decision making. Expert Opinion on Pharmacotherapy 8:sup1, pages S5-S14.
Read now

Articles from other publishers (3)

Liese Barbier, Yannick Vandenplas, Niels Boone, Isabelle Huys, Rob Janknegt & Arnold G Vulto. (2022) How to select a best-value biological medicine? A practical model to support hospital pharmacists. American Journal of Health-System Pharmacy 79:22, pages 2001-2011.
Crossref
Niels Boone, Hugo van der Kuy, Mike Scott, Jill Mairs, Irene Krämer, Arnold Vulto & Rob Janknegt. (2013) How to select a biosimilar. European Journal of Hospital Pharmacy 20:5, pages 275-286.
Crossref
Robert Janknegt, Robert Brenninkmeijer, Mike Scott & Steven Simoens. (2010) Matrix Models as an Instrument to Support Generic Medicine Prescribing. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 7:4, pages 334-341.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.